BrinkerAllenMD

Journal Articles

• Association of Noninfectious Pneumonia With Ustekinumab Use  
  Brinker A, Cheng C, Chan V, JAMA Dermatol, 1/1/2018
• Eluxadoline-associated acute pancreatitis-myth or reality? Authors' reply (letter)  
  Harinstein L, Wu E, Brinker A, Aliment Pharmacol Ther, 1/1/2018
• Acute acalculous cholecystitis: A new safety risk for patients with MS treated with alemtuzumab  
  Croteau D, Flowers C, Kulick CG, Brinker A, Kortepeter CM, Neurology, 1/1/2018
• Postmarketing cases of eluxadoline-associated pancreatitis in patients with or without a gallbladder  
  Harinstein L, Wu E, Brinker A, Aliment Pharmacol Ther, 1/1/2018
• Serious Liver Injury Associated with Macitentan: A Case Report  
  Tran TT, Brinker AD, Mu�oz M, Pharmacotherapy, 1/1/2018
• Etonogestrel implant migration to the vasculature, chest wall, and distant body sites: cases from a pharmacovigilance database  
  Kang S, Niak A, Gada N, Brinker A, Jones SC, Contraception, 1/1/2017
• Response to: Improvement of sleep architecture parameters in cirrhotic patients with recurrent hepatic encephalopathy with the use of rifaximin: hepatic encephalopathy...  
  Nevo ON, Brinker AD, Diak IL, Kortepeter CM, Eur J Gastroenterol Hepatol, 1/1/2017
• Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus: A Review of Cases Reported to the US Food and Drug Admini...  
  Bersoff-Matcha SJ, Cao K, Jason M, Ajao A, Jones SC, Meyer T, Brinker A, Ann Intern Med, 1/1/2017
• Chemical Leukoderma Associated with Methylphenidate Transdermal System: Data From the US Food and Drug Administration Adverse Event Reporting System  
  Cheng C, La Grenade L, Diak IL, Brinker A, Levin RL, J Pediatr, 1/1/2017
• Data Mining of the US FDA�s Adverse Events Reporting System Database to Evaluate Drug�Drug Interactions Associated with Statin-Induced Rhabdomyolysis  
  Mu�oz MA, Tonning JM, Brinker AD, Delaney JAC, Gatti JC, Avigan M, Pharmaceutical Medicine, 1/1/2016
• Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the US Food and Drug Administration Adverse Event Reporting System  
  Jones SC, Ryan DL, Pratt VS, Niak A, Brinker AD, Diabetes Spectr, 1/1/2015
• Profiling Cumulative Proportional Reporting Ratios of Drug-Induced Liver Injury in the FDA Adverse Event Reporting System (FAERS) Database  
  Brinker AD, Lyndly J, Tonning J, Moeny D, Levine JG, Avigan MI, Drug Safety, 1/1/2013
• Spontaneous reports of seizure in association with leuprolide (lupron depot), goserelin (zoladex implant), and naferelin (synarel nasal spray) (letter)  
  Gatti J, Brinker A, Avigan, Obstet Gynecol, 1/1/2013
• Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients  
  Kothary N, Diak IL, Brinker A, Bezabeh S, Avigan M, Pan GD, J Am Acad Dermatol, 1/1/2011
• Sitagliptin-associated drug allergy: review of spontaneous adverse event reports  
  Desai S, Brinker A, Swann J, Iyasu S, Arch Intern Med, 1/1/2010
• Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors  
  Rowan C, Brinker AD, Nourjah P, Chang J, Mosholder A, Barrett JS, Avigan M, Pharmacoepidemiol Drug Saf, 1/1/2009
• Allopurinol and the Role of Uric Acid in Hypertension (letter)  
  Brinker, AD, JAMA, 1/1/2009
• Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases  
  Brinker AD, Wassel RT, Lyndly J, Serrano J, Avigan M, Lee WM, Seeff LB, Hepatology, 1/1/2009
• Characteristics of spontaneous cases of tuberculosis associated with infliximab  
  Raval A, Akhavan-Toyserkani G, Brinker A, Avigan M, Ann Intern Med, 1/1/2007
• Indication and use of drug products used to treat attention-deficit/hyperactivity disorder: a cross-sectional study with inference on the likelihood of treatment in ad...  
  Brinker A, Mosholder A, Schech SD, Burgess M, Avigan M, J Child Adolesc Psychopharmacol, 1/1/2007
• An observational study of cholecystectomy in patients receiving tegaserod  
  Brinker A, Schech SD, Burgess M, Avigan M, Drug Saf, 1/1/2007
• New-onset and idiopathic thrombotic thrombocytopenic purpura: Incidence, diagnostic validity, and potential risk factors  
  Schech SD, Brinker A, Shatin D, Burgess M, Am J Hematol, 1/1/2006
• Trends in the use of ipecac in the ED setting: data from the 1992-2002 NHAMCS-ED (letter)  
  Brinker AD, Nourjah P, Am J Emerg Med, 1/1/2006
• Alosetron: ischemic colitis and serious complications of constipation  
  Gallo-Torres H, Brinker A, Avigan M, Am J Gastroenterol, 1/1/2006
• Growth in Clopidogrel-Aspirin Combination Therapy (letter)  
  Brinker AD, Swartz L, Ann Pharmacother, 1/1/2006
• Join now to see all

Books/Book Chapters

• Drug-Induced Liver Toxicity 
  Chapter: Postmarketing Surveillance of Drug-Induced Liver Injury 
  Jones SC, Kortepeter C, Brinker ADEditors: M Chen and Y Will.Humana Press2018